01 1Shandong Anhong Pharmaceutical
01 1LASMIDITAN HEMISUCCINATE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-09-18
Pay. Date : 2023-06-08
DMF Number : 38429
Submission : 2023-07-31
Status : Active
Type : II
20
Shandong Anhong Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is LASMIDITAN HEMISUCCINATE, with a corresponding US DMF Number 38429.
Remarkably, this DMF maintains an Active status since its submission on July 31, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 18, 2023, and payment made on June 08, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
